Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.

Psychedelics are serendipity drugs; the in vivo renaissance is the forward bet. Bostwick confirms Breyer has no psychedelic thesis, though he learns.